Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial

H Azizi, N Rouhani, F Shaki… - International …, 2021 - Elsevier
Pentoxifylline (PTX) has broad-spectrum properties such as anti-inflammatory,
anticoagulant, and antiviral effects. The aim of this study was to evaluate the efficacy and …
被引用次数：6 相关文章

Pentoxifylline effects on hospitalized patients with COVID19: a randomized, double-blind clinical trial.

H Azizi, N Rouhani, F Shaki, E Karimpour-razkenari… - 2021 - cabidigitallibrary.org
Pentoxifylline (PTX) has broad-spectrum properties such as anti-inflammatory,
anticoagulant, and antiviral effects. The aim of this study was to evaluate the efficacy and …

Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial.

H Azizi, N Rouhani, F Shaki… - International …, 2021 - europepmc.org
Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical
trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial

H Azizi, N Rouhani, F Shaki, E Karimpour-Razkenari… - 2021 - pubmed.ncbi.nlm.nih.gov
Pentoxifylline (PTX) has broad-spectrum properties such as anti-inflammatory,
anticoagulant, and antiviral effects. The aim of this study was to evaluate the efficacy and …
[HTML] nih.gov

[HTML][HTML] Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial

H Azizi, N Rouhani, F Shaki… - International …, 2021 - ncbi.nlm.nih.gov
Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind
clinical trial - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …